Search Results - "Burghart L"

Editorial: Tracking the course of Wilson's disease: Authors' reply.

Authors: Burghart L Reiberger T Staettermayer AF

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Sep; Vol. 60 (6), pp. 813-814. Date of Electronic Publication: 2024 Aug 09.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis': Authors' Reply.

Authors: Burghart L Reiberger T Stättermayer AF

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Apr; Vol. 63 (7), pp. 1070-1072. Date of Electronic Publication: 2026 Feb 16.

Publication Type: Letter

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply.

Authors: Burghart L Hofer BS Halilbasic E et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jul; Vol. 60 (1), pp. 107-108. Date of Electronic Publication: 2024 May 27.

Publication Type: Letter; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

Authors: Hofer BS Burghart L Halilbasic E et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 May; Vol. 59 (9), pp. 1146-1147.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; PubMed not MEDLINE

Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients.

Authors: Secondulfo, Carmine Russo, Dora Vecchione, Nicoletta et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4832. 10p.

Effects of SGLT2 Inhibitors on Proteinuria and Renal Function Parameters in Non-Diabetic Kidney Transplant Recipients: A Retrospective Cohort Study Based on 12-Month Follow-Up Data.

Authors: Kahvecioglu, Serdar Celik, Huseyin Karatutlu, Asena Serap et al.

Source: Journal of Clinical Medicine. Jul2026, Vol. 15 Issue 13, p5303. 10p.

A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in Vienna.

Authors: Schwarz C Schütz A Anibas M et al.

Source: Journal of virus eradication [J Virus Erad] 2025 Oct 02; Vol. 11 (4), pp. 100611. Date of Electronic Publication: 2025 Oct 02 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101654142 Publication Model: eCollection Cited Medium: Print ISSN: 2055-6640 (Print) Linking ISSN: 20556640 NLM ISO Abbreviation: J Virus Erad Subsets: PubMed not MEDLINE

Association Between Sarcopenic Obesity–Related Scores and Liver Fibrosis in Patients with Steatotic Liver Disease: A Cross-Sectional Study.

Authors: Ichikawa, Tatsuki Miuma, Satoshi Yamashima, Mio et al.

Source: Diagnostics (2075-4418). Jan2026, Vol. 16 Issue 2, p324. 17p.

Assessment of Liver Fibrosis Stage and Cirrhosis Regression After Long-Term Follow-Up Following Sustained Virological Response.

Authors: Canillas, Lidia Naranjo, Dolores Broquetas, Teresa et al.

Source: Diagnostics (2075-4418). Jan2026, Vol. 16 Issue 2, p279. 16p.

GLP-1 Receptor Agonists and SGLT2 Inhibitors in Stable Kidney Transplantation: Clinical Outcomes from a Cohort of Patients with Post-Transplant Diabetes Mellitus.

Authors: Navarrete, Ricardo E. T. Freitas, Joana Fonseca, Isabel et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p181. 16p.

失代偿期肝硬化患者再代偿的长期预后.

Alternate Title: Long-term prognosis of recompensation in patients with decompensated liver cirrhosis.

Authors: 谢, 志伟 李, 波 林, 丽花 et al.

Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Jun2026, Vol. 42 Issue 6, p1246-1252. 7p.

Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes.

Authors: Schwarz M Schwarz C Burghart L et al.

Source: PloS one [PLoS One] 2023 Aug 24; Vol. 18 (8), pp. e0290352. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice.

Authors: Gómez, E. Montero, J. L. Molina, E. et al.

Source: Alimentary Pharmacology & Therapeutics. Jun2024, Vol. 59 Issue 12, p1604-1615. 12p.

Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records.

Authors: Lentine, Krista L. Miyata, Kana N. Lam, Ngan N. et al.

Source: Clinical Transplantation. Apr2024, Vol. 38 Issue 4, p1-7. 7p.

Diabetes Mellitus in Kidney Transplant Recipients and New Hypoglycemic Agent Options.

Authors: Bartoli, Giulia Dello Strologo, Andrea Arena, Maria et al.

Source: International Journal of Molecular Sciences. Jul2025, Vol. 26 Issue 13, p5952. 17p.

Porto-Sinusoidal Vascular Disorder: An Under-Recognized Liver Manifestation in Turner Syndrome.

Authors: Siasiakou, Sofia M. Stoupi, Eleni Roumpou, Afroditi et al.

Source: Journal of Clinical Medicine. Jun2025, Vol. 14 Issue 11, p3979. 12p.

Non-invasive assessment of esophageal and fundic varices in patients with primary biliary cholangitis.

Authors: Zhang, Yuan Huang, Chunyang Meng, Fankun et al.

Source: European Radiology. Apr2025, Vol. 35 Issue 4, p2330-2338. 9p.

Subjects: Gastric varices, Esophageal varices, Receiver operating characteristic curves, Varicose veins, Reference values

Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis.

Authors: Dalekos, George N. Gatselis, Nikolaos Androutsakos, Theodoros et al.

Source: Annals of Gastroenterology. 2026, Vol. 39 Issue 2, p123-160. 39p.

Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target‐Trial Emulation.

Authors: Huang, Yu‐Nan Tsou, Min‐Yu Li, Pin‐Hung et al.

Source: Advanced Science. 2/23/2026, Vol. 13 Issue 11, p1-21. 21p.

Administration of sodium-glucose cotransporter-2 inhibitors in kidney transplant patients with diabetes: a systematic review and meta-analysis.

Authors: Khodabandeh, Hamidreza Bakhshizade, Zahra Taklif, Mohammad Hossein et al.

Source: Journal of Nephropathology. Oct2023, Vol. 12 Issue 4, p1-10. 10p.